Microbix: Microbix Presenting at the 2025 Bloom Burton Conference

MISSISSAUGA, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:MBX, OTCQX: MBXBF, Microbix®), (TSX: MBX, OTCQX:MBXBF, Microbix®), Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the 2025 Bloom Burton & Co. Healthcare Investor Conference (the "Conference") taking place at the Metro Toronto Convention Centre, North Building, on Monday and Tuesday, May 5 & 6, 2025.The Conference provides Microbix the opportunity to build connections with Canadian, U.S., and international investors focused on the latest developments in the Canadian healthcare and life sciences sector. Microbix's CEO & President, Cameron Groome, will make an in-person group presentation to investors on Tuesday, May 6 at 2:30 p.m. Eastern Time. Additionally, Senior management will participate in many one-on-one meetings with investors at the Conference. The Microbix presentation slides will be available for download at https://microbix.com.About Bloom Burton & Co.Bloom Burton & Co. is dedicated to accelerating returns in the healthcare sector for both investors and companies. It has an experienced team of medical, scientific, industry, and capital markets professionals who perform a deep level of diligence, which combined with its creative and entrepreneurial approach, assists its clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, strategic advisory, as well as company creation & incubation services. Bloom Burton Securities Inc. is regulated by the Canadian Investment Regulatory Organization (CIRO) and is a member of ...Full story available on Benzinga.com